Cell biology at ChemPartner combines scientific know-how with strong technical expertise to provide the best possible cell-based assay solutions to our customers. Over the past decade, we have built up an A-to-Z full spectrum platform cell-based assay platform to support drug discovery from target validation, hit to lead, and lead optimization to preclinical candidate selection.
Additionally, our team has established hundreds of cell-based assays for profiling cellular phenotypes, oncogenic signaling, DNA damage response, protein degradation, cancer metabolism, and epigenetics.
We have banked an extensive panel of 800+ cancer cell lines (including some proprietary to ChemPartner) for large-scale cancer cell line panel screening. Our track record of high-quality data and on-time delivery has made us the trusted partner for hundreds of pharmaceutical and biotech partners worldwide.
